Cradle raised USD 73 million in a Series B round led by IVP, with participation from Index Ventures and Kindred Capital. The protein-engineering software company, with operations in the Netherlands and Zurich, said the investment brought cumulative funding above USD 100 million. It reported more than 21 customers and 31 proteins under development after beginning to commercialise its platform earlier in 2024.
Its software combined generative models with laboratory results to suggest protein sequences with desired properties. Cradle planned to expand its wet laboratory, investigate additional protein types and properties, grow its engineering team and broaden commercial operations.
